ArticleFrontiers in cardiovascular medicine2025
Cardiac abnormalities and repolarization variability in epilepsy: influence of antiseizure medications and treatment response.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the effects of different antiseizure medications (ASMs) and clinical treatment response on interictal electrocardiographic (ECG) repolarization indices and echocardiographic structural and functional cardiac parameters in patients with epilepsy. Methods: This single-center, prospective, cross-sectional study was conducted between August 2024 and February 2025 at the Neurology and Cardiology Departments of Siirt Training and Research Hospital. The study included 97 patients with epilepsy and 57 age- and sex-matched healthy controls. Patients were classified as drug-sensitive or drug-resistant based on the International League Against Epilepsy (ILAE) criteria. While both monotherapy and polytherapy users were included in clinical comparisons, subgroup analyses by ASM type involved only monotherapy patients. ECG and echocardiographic parameters were assessed. Group comparisons and correlation analyses were performed using analysis of variance (ANOVA), chi-square test, and Pearson correlation. Results: No significant differences in demographic or interictal ECG repolarization indices were found between the drug-sensitive, drug-resistant, and control groups ( Conclusion: Treatment with ASMs in epilepsy is associated with left atrial enlargement, particularly with CBZ. The absence of interictal ECG repolarization differences suggests that isolated assessments may be insufficient, supporting long-term cardiac monitoring in epilepsy management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.